Abstract
Acetylcholinesterase inhibitors (AChEIs) may counteract the anticholinergic properties of certain atypical antipsychotics (AAs) and thereby affect the adverse outcomes in dementia patients. This study evaluated the risk of falls and fractures due to the concomitant use of AChEIs and AAs (classified as high-level versus low-level anticholinergic) among older adults with dementia.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
